Skip to main content

Page of 6
and
  1. Article

    Open Access

    Disruption of the MDM2–p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway

    Wild-type p53 has a major role in the response and execution of apoptosis after chemotherapy in many cancers. Although high levels of wild-type p53 and hardly any TP53 mutations are found in testicular cancer (TC...

    R Koster, H Timmer-Bosscha, R Bischoff, J A Gietema, S de Jong in Cell Death & Disease (2011)

  2. Article

    Open Access

    Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer

    Tumour-infiltrating lymphocytes (TILs) are predictors of disease-specific survival (DSS) in ovarian cancer. It is largely unknown what factors contribute to lymphocyte recruitment. Our aim was to evaluate gene...

    N Leffers, R S N Fehrmann, M J M Gooden, U R J Schulze in British Journal of Cancer (2010)

  3. Article

    Open Access

    Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis

    P53, EGFR and HER-2/neu are the most frequently studied molecular biological parameters in epithelial ovarian cancer, but their prognostic impact is still unequivocal. We performed a meta-analysis to more prec...

    P de Graeff, A P G Crijns, S de Jong, M Boezen, W J Post in British Journal of Cancer (2009)

  4. No Access

    Article

    Network analysis of positional candidate genes of schizophrenia highlights myelin-related pathways

    T Rietkerk, M P M Boks, I E C Sommer, S de Jong, R S Kahn in Molecular Psychiatry (2009)

  5. Article

    Arginine metabolism in a small animal model of sepsis and after hemihepatectomy

    B Van der Hoven, T Teerlink, S De Jong, P Van Leeuwen, J Bakker, D Gommers in Critical Care (2009)

  6. Article

    Open Access

    Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL

    Although the tyrosine kinase inhibitor imatinib has been shown to be an active agent in patients with gastrointestinal stromal tumours (GIST), complete remissions are almost never seen and most patients finall...

    B Rikhof, W T A van der Graaf, C Meijer, P T K Le, G J Meersma in British Journal of Cancer (2008)

  7. Article

    Open Access

    The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer

    Ovarian cancer is the most frequent cause of death from gynaecological cancer in the Western world. Current prognostic factors do not allow reliable prediction of response to chemotherapy and survival for indi...

    P de Graeff, A P G Crijns, K A ten Hoor, H G Klip, H Hollema in British Journal of Cancer (2008)

  8. Article

    Open Access

    Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1

    Small-cell lung cancers (SCLCs) initially respond to chemotherapy, but are often resistant at recurrence. The non-steroidal anti-inflammatory drug indomethacin is an inhibitor of multidrug resistance protein 1...

    D J A de Groot, M van der Deen, T K P Le, A Regeling in British Journal of Cancer (2007)

  9. Article

    Open Access

    Reply: The classification of p53 immunohistochemical staining results and patient outcome in ovarian cancer

    P de Graeff, J Hall, A P G Crijns, G H de Bock, J Paul in British Journal of Cancer (2007)

  10. Article

    Open Access

    Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies

    The prognostic impact of p53 immunostaining in a large series of tumours from epithelial ovarian cancer patients in a two-centre study was analysed. The study population (n=476) comprised of a retrospective serie...

    P de Graeff, J Hall, A P G Crijns, G H de Bock, J Paul in British Journal of Cancer (2006)

  11. No Access

    Article

    Search for neutral MSSM Higgs bosons at LEP

    The four LEP collaborations, ALEPH, DELPHI, L3 and OPAL, have searched for the neutral Higgs bosons which are predicted by the Minimal Supersymmetric standard model (MSSM). The data of the four collaborations ...

    S. Schael, R. Barate, R. Brunelière in The European Physical Journal C - Particle… (2006)

  12. Article

    Open Access

    Indomethacin-induced activation of the death receptor-mediated apoptosis pathway circumvents acquired doxorubicin resistance in SCLC cells

    Small-cell lung cancers (SCLCs) initially respond to chemotherapy but are often resistant at recurrence. A potentially new method to overcome resistance is to combine classical chemotherapeutic drugs with apop...

    D J A de Groot, T Timmer, D C J Spierings, T K P Le, S de Jong in British Journal of Cancer (2005)

  13. Article

    Open Access

    Induction of hyperammonia in irradiated hepatoma cells: a recapitulation and possible explanation of the phenomenon

    J van Rijn, J van den Berg, R G Schipper, S de Jong in British Journal of Cancer (2004)

  14. Article

    Open Access

    Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines

    Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and CD95 ligand (CD95L) are potent inducers of apoptosis in various tumour cell types. Death receptors DR4 and DR5 can induce and decoy receptor...

    C M M van Geelen, E G E de Vries, T K P Le, R P van Weeghel in British Journal of Cancer (2003)

  15. Article

    Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line

    Testicular germ cell tumors (TGCTs) are unusually sensitive to cisplatin. In the present study the role of the CD95 death pathway in cisplatin sensitivity of TGCT cells was studied in Tera and its in vitro acquir...

    D C J Spierings, E G E de Vries, E Vellenga, S de Jong in Cell Death & Differentiation (2003)

  16. No Access

    Article

    Alzheimer's disease is not associated with altered concentrations of the nitric oxide synthase inhibitor asymmetric dimethylarginine in cerebrospinal fluid

    Nitric oxide (NO) may play a role in the pathophysiology of Alzheimer's disease (AD). Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO synthase, is involved in regulation of NO production. Re...

    C. Mulder, L.-O. Wahlund, M. Blomberg, S. de Jong in Journal of Neural Transmission (2002)

  17. Article

    Open Access

    Cytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1

    Anthranoid laxatives, belonging to the anthraquinones as do anthracyclines, possibly increase colorectal cancer risk. Anthracyclines interfere with topoisomerase II, intercalate DNA and are substrates for P-gl...

    B A P van Gorkom, H Timmer-Bosscha, S de Jong in British Journal of Cancer (2002)

  18. Article

    Open Access

    Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation

    High-dose chemotherapy and peripheral blood stem cell transplantation (PBSCT) may accelerate telomere length loss in haematopoietic stem cells. As data including pre-and post-treatment samples are lacking, we ...

    C P Schröder, G B A Wisman, S de Jong, W T A van der Graaf in British Journal of Cancer (2001)

  19. No Access

    Article

    Death Receptor Ligands, in Particular TRAIL, to Overcome Drug Resistance

    The efficacy of chemotherapeutic drugs is hampered by the occurrence of intrinsic and acquired drug resistance. A variety of mechanisms cause drug-resistance. A final common factor, however, is the reduced cap...

    S. de Jong, T. Timmer, F.J. Heijenbrok, E.G.E. de Vries in Cancer and Metastasis Reviews (2001)

  20. Article

    Open Access

    DNA topoisomerase IIα and -β expression in human ovarian cancer

    To study DNA topoisomerase IIα (Topo-IIα) and -β expression and regulation in human ovarian cancer, 15 ovarian tumour samples were investigated. To compare different levels of expression, the samples were scre...

    S Withoff, A G J van der Zee, S de Jong, H Hollema, E F Smit in British Journal of Cancer (1999)

Page of 6